Search

Read an interview with Sloan Kettering Institute immunologist Justin Perry.

… Friday, January 1, 2021 Immunologist Justin Perry came to the Sloan Kettering Institute (SKI) in 2019, after completing his graduate studies at Washington University in St. Louis and a postdoctoral fellowship at the University of Virginia. His lab studies cell death and how the body deals with the millions

Memorial Sloan Kettering Cancer Center (MSK) experts presented their latest advances in oncology research at the American Association for Cancer Research (AACR) Annual Meeting 2025, held April 25 to 30 in Chicago.

… Tuesday, April 29, 2025 Memorial Sloan Kettering Cancer Center (MSK) experts presented their latest advances in oncology research at the American Association for Cancer Research (AACR) Annual Meeting 2025, held April 25 to 30 in Chicago.  Highlights included breakthrough findings in mismatch-repair deficient

Hear from our experts about a new study linking alcohol consumption and melanoma risk.

… Friday, December 2, 2016 Summary The association between alcohol and cancer risk is well known. But a new study attempts to draw a direct tie between drinking alcohol and developing melanoma. Two MSK experts weigh in on the findings. Highlights A new analysis found that alcohol intake was associated

… Wednesday, October 1, 2008 October 2008 - The school welcomes five new faculty members. Julia Kaltschmidt Developmental Biology Research Interests: Understanding the mechanisms of synaptic specificity underlying neuronal circuit formation. Minkui Luo Molecular Pharmacology and Chemistry Research Interests

Read about a discovery that a gene linked to pediatric cancers may play an essential role in normal brain development.

… Wednesday, January 14, 2026 When scientists discover new cancer-related genes, their primary concern is learning how the mutation triggers runaway cell growth. It is often much easier to see how things go awry than to decipher the gene’s normal function — and to determine if that function is actually

Memorial Sloan Kettering Cancer Center today launched a transformative initiative to improve the quality of cancer care and the lives of cancer patients. Hartford HealthCare, a multi-hospital health care system in Connecticut, was selected as a pioneering member of the newly formed Memorial Sloan Kettering Cancer Alliance.

… Tuesday, September 17, 2013 Hartford HealthCare Selected to Be First MSK Cancer Alliance Member Memorial Sloan Kettering Cancer Center today launched a transformative initiative to improve the quality of cancer care and the lives of cancer patients. Hartford HealthCare, a multi-hospital health care system

Black adults are more likely to get colorectal cancer and die from it than any other group. Learn how Black men and women can protect themselves and why screening for colorectal cancer beginning at age 45 is so important.

… Friday, June 4, 2021 One of the cruel realities of cancer is that Black men and women are more likely to get colorectal cancer than any other racial or ethnic group in the country — and even worse, are more likely to die of the disease. Black adults and colorectal cancer Highest rate of any racial/ethnic

A study from MSK takes a deeper look at some of the causes of secondary leukemia.

… Monday, September 9, 2019 Summary A new study from Memorial Sloan Kettering suggests that in some people treated for breast cancer, leukemia-causing gene mutations may be present in blood cells from the time the original cancer was diagnosed. This helps explain some cases of secondary leukemia. Doctors

Learn how it's possible to stay active even with two types of advanced cancer — lung cancer and mantle cell lymphoma — thanks to innovative treatments at MSK.

… Thursday, December 5, 2024 To see Michael Simien darting in and out of New York City streets on his bike, you’d never guess he is 70 years old — let alone that he is living with two kinds of metastatic cancer: lung cancer that was diagnosed 10 years ago and a rare, aggressive type of non-Hodgkin lymphoma

Descubra cómo es posible mantenerse activo incluso con dos tipos de cáncer avanzado, cáncer pulmonar y linfoma de células del manto, gracias a los tratamientos innovadores en MSK.

… Thursday, December 5, 2024 Al ver a Michael Simien entrar y salir y moverse rápido como una flecha por las calles de Nueva York en bicicleta, nunca adivinaría que tiene 70 años, y mucho menos que padece dos tipos de cáncer metastásico: cáncer pulmonar que le diagnosticaron hace 10 años y un tipo raro